Citrus Fruits Lower Risk of Stroke

These Juicy Delights Pack Health Benefits




Popular winter citrus fruits like oranges and grapefruit come with an unexpected health benefit: eating them may lower the risk of ischemic strokes (clots), especially in women, per a study reported in Stroke, a journal of the American Heart Association.

The researchers analyzed 14 years of follow-up data from the National Institutes of Health Nurses’ Health Study, which included 69,622 women that reported their food intake every four years, including details on fruit and vegetable consumption. The study discovered that a high intake of flavanones, a subclass of flavonoids found in the greatest concentrations in oranges and grapefruit, was associated with a 19 percent lower risk of ischemic stroke.

In the study, the presence of flavanones came primarily from oranges and orange juice (82 percent) and grapefruit and grapefruit juice (14 percent). However, the researchers recommended that consumers increase their citrus fruit intake, rather than juice consumption, to avoid the sugar in many commercial juices.

Edit ModuleShow Tags

More from Natural Awakenings

Eating Apples and Tomatoes Repairs Lungs

Fresh tomatoes and fruit, especially apples, help heal damaged lungs of ex-smokers and can slow the natural decline of lung function that typically occurs after age 30.

Gooseberries are Good for the Gut

Malaysian subjects with gastrointestinal problems had less pain, vomiting and sleep loss when receiving an ayurvedic remedy known as Indian gooseberry.

Chocolate and Olive Oil Help Heart Health

Italians eating dark chocolate combined with olive oil had lower cholesterol and blood pressure in just 28 days.

Lutein in Greens and Eggs Slows Cognitive Aging

In a University of Illinois study, adults that ate large amounts of leafy greens, avocados and eggs had levels of lutein, a brain and eye nutrient, on par with younger people.

Tree Nuts Cut Colon Cancer Relapse

Two or more ounces of tree nuts a week sharply reduced cancer recurrence and premature death risk in patients with Stage III colon cancer.
Edit ModuleShow Tags
Edit ModuleShow Tags